Teva Pharmaceuticals is buying Allergan's generic drug unit for $40.5 billion — here's why so many health care companies are merging
Teva Launches Honestly HD Website to Provide People Living With Huntington's Disease (HD) Information, Inspiration and Resources on HD Chorea
![Teva: Copaxone And Management Uncertainty May Be Hiding One Of The Last Bargains Around (NYSE:TEVA) | Seeking Alpha Teva: Copaxone And Management Uncertainty May Be Hiding One Of The Last Bargains Around (NYSE:TEVA) | Seeking Alpha](https://static.seekingalpha.com/uploads/2012/10/458328_13516887561736_rId6.png)